|
LRRC8C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.623580E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.793000E-01 |
| Normal-vs-Stage2 |
7.824600E-01 |
| Normal-vs-Stage3 |
1.252020E-01 |
| Normal-vs-Stage4 |
3.002700E-03 |
| Stage1-vs-Stage2 |
6.150800E-01 |
| Stage1-vs-Stage3 |
2.134000E-01 |
| Stage1-vs-Stage4 |
2.979200E-03 |
| Stage2-vs-Stage3 |
2.201000E-01 |
| Stage2-vs-Stage4 |
5.381800E-03 |
| Stage3-vs-Stage4 |
9.405500E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.415760E-01 |
| Normal-vs-AfricanAmerican |
6.181900E-02 |
| Normal-vs-Asian |
1.464820E-01 |
| Caucasian-vs-AfricanAmerican |
2.916000E-01 |
| Caucasian-vs-Asian |
7.196800E-01 |
| AfricanAmerican-vs-Asian |
4.119000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.794600E-01 |
| Normal-vs-Female |
1.256980E-01 |
| Male-vs-Female |
5.156400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.975800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.732400E-02 |
| Normal-vs-Age(61-80Yrs) |
3.194200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.411000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.412840E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.359400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.578600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.126600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.868000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.227400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.669810E-01 |
| Classical-VS-Follicular |
4.609900E-02 |
| Classical-VS-Other |
6.931600E-02 |
| Classical-VS-Normal |
1.673950E-01 |
| Tall-VS-Follicular |
1.545880E-02 |
| Tall-VS-Other |
3.358200E-01 |
| Tall-VS-Normal |
4.079700E-02 |
| Follicular-VS-Other |
2.478400E-02 |
| Follicular-VS-Normal |
8.548200E-01 |
| Other-VS-Normal |
3.229600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.754800E-01 |
| Normal-vs-N1 |
1.089700E-02 |
| N0-vs-N1 |
2.382500E-02 |
|
|
